| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 18 | 20 | 730 | $2,870 | $3.5M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 170 | 340 | 1,090 | $70 | $1.4M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 29 | 180 | 3,200 | $90 | $1M |
| 90834 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 1,674 | 2,200 | 1,010 | $130 | $892.2K |
| 92507 | The provider treats a patient with communication and hearing difficulties by directly interacting with the patient. He assesses the patient with impairment in his ability to make sounds, along with… | 156 | 750 | 1,800 | $80 | $785.8K |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 1,176 | 1,420 | 90 | $130 | $715.2K |
| C1889 | Implantable/insertable device, not otherwise classified | 11 | 40 | 320 | $260 | $533.3K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 1,857 | 2,210 | 80 | $130 | $473K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 170 | 300 | 1,710 | $20 | $458.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 27 | 90 | 260 | $360 | $435.5K |